Clinical Trials Browser

Phase 1/2 × Carcinoma × Plasma cell × Clear all

NCT03915184 2023-12-19

Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)

Phase 1/2 Active not recruiting

Carcinoma, Multiple Myeloma